Skip to main content
OpenTrials

Clinical trial condition

Spasticity

Explore clinical trials studying Spasticity. Study availability and eligibility vary by location and protocol.

91 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Spasticity trial results

Completed

One Year, Open Label, Dose Escalation Long-term Safety Study in Multiple Sclerosis (MS) Subjects With Spasticity

NCT01844232

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +13 more
Locations
  • Osmotica Study Site-154 Gilbert, Arizona, United States
  • Osmotica Study Site-158 Phoenix, Arizona, United States
  • Osmotica Study Site-165 Pasadena, California, United States
  • Osmotica Study Site-164 Torrance, California, United States
View all 35 locations
View Trial Details
Completed

Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis

NCT01743651

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +13 more
Locations
  • Osmotica Study Site-138 Cullman, Alabama, United States
  • Osmotica Site-143 Long Beach, California, United States
  • Osmotica Study Site-123 Aurora, Colorado, United States
  • Osmotica Study Site-110 Bradenton, Florida, United States
View all 48 locations
View Trial Details

Related conditions